Literature DB >> 24357321

CRL4 complex regulates mammalian oocyte survival and reprogramming by activation of TET proteins.

Chao Yu1, Yin-Li Zhang, Wei-Wei Pan, Xiao-Meng Li, Zhong-Wei Wang, Zhao-Jia Ge, Jian-Jie Zhou, Yong Cang, Chao Tong, Qing-Yuan Sun, Heng-Yu Fan.   

Abstract

The duration of a woman's reproductive period is determined by the size and persistence of a dormant oocyte pool. Specific oocyte genes are essential for follicle maintenance and female fertility. The mechanisms that regulate the expression of these genes are poorly understood. We found that a cullin-ring finger ligase-4 (CRL4) complex was crucial in this process. Oocyte-specific deletion of the CRL4 linker protein DDB1 or its substrate adaptor VPRBP (also known as DCAF1) caused rapid oocyte loss, premature ovarian insufficiency, and silencing of fertility maintaining genes. CRL4(VPRBP) activates the TET methylcytosine dioxygenases, which are involved in female germ cell development and zygote genome reprogramming. Hence, CRL4(VPRBP) ubiquitin ligase is a guardian of female reproductive life in germ cells and a maternal reprogramming factor after fertilization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24357321     DOI: 10.1126/science.1244587

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  52 in total

Review 1.  Epigenetic regulation of early neural fate commitment.

Authors:  Yunbo Qiao; Xianfa Yang; Naihe Jing
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

Review 2.  TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.

Authors:  Yami Liu; Wen Peng; Kai Qu; Xiaolong Lin; Zhaolin Zeng; Jiaojiao Chen; Dangheng Wei; Zuo Wang
Journal:  DNA Cell Biol       Date:  2018-04-13       Impact factor: 3.311

3.  VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.

Authors:  Yihao Li; Chao Cui; Feng Xie; Szymon Kiełbasa; Hailiang Mei; Maarten van Dinther; Hans van Dam; Andreas Bauer; Long Zhang; Peter Ten Dijke
Journal:  J Mol Cell Biol       Date:  2020-02-20       Impact factor: 6.216

4.  Mediation by Placental DNA Methylation of the Association of Prenatal Maternal Smoking and Birth Weight.

Authors:  Andres Cardenas; Sharon M Lutz; Todd M Everson; Patrice Perron; Luigi Bouchard; Marie-France Hivert
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

Review 5.  TET2 in Normal and Malignant Hematopoiesis.

Authors:  Robert L Bowman; Ross L Levine
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

6.  CNOT6L couples the selective degradation of maternal transcripts to meiotic cell cycle progression in mouse oocyte.

Authors:  Qian-Qian Sha; Jia-Li Yu; Jing-Xin Guo; Xing-Xing Dai; Jun-Chao Jiang; Yin-Li Zhang; Chao Yu; Shu-Yan Ji; Yu Jiang; Song-Ying Zhang; Li Shen; Xiang-Hong Ou; Heng-Yu Fan
Journal:  EMBO J       Date:  2018-11-26       Impact factor: 11.598

7.  Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo.

Authors:  Changqing Wu; Bo Xu; Xiaoyong Li; Wenzhi Ma; Ping Zhang; Xuejin Chen; Ji Wu
Journal:  Mol Ther       Date:  2017-05-18       Impact factor: 11.454

Review 8.  Reprogramming the genome to totipotency in mouse embryos.

Authors:  Li-quan Zhou; Jurrien Dean
Journal:  Trends Cell Biol       Date:  2014-10-21       Impact factor: 20.808

9.  Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.

Authors:  Ai-Hua Wu; Dong-Yu Yang; Yu-Dong Liu; Xin Chen; Xu-Long Chen; Shan Lu; Shi-Ling Chen
Journal:  Curr Med Sci       Date:  2018-06-22

10.  Mammalian nucleolar protein DCAF13 is essential for ovarian follicle maintenance and oocyte growth by mediating rRNA processing.

Authors:  Jue Zhang; Yin-Li Zhang; Long-Wen Zhao; Jing-Xin Guo; Jia-Li Yu; Shu-Yan Ji; Lan-Rui Cao; Song-Ying Zhang; Li Shen; Xiang-Hong Ou; Heng-Yu Fan
Journal:  Cell Death Differ       Date:  2018-10-03       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.